OLANZAPINE FACT SHEET
(O - lan - zar - peen)
This information is not a replacement for a full discussion of risks and benefits with your doctor.
Other Names: Zyprexa.
Principal Uses: Schizophrenia, Bipolar Mania and Bipolar Depression.
Cost: (In New Zealand). Fully subsidised if Pharmac approved. To get approval your doctor applies to Pharmac and is given a prescibing number for you which is given to your pharmacist or written on your script.
Dose: This can vary but the usual starting dose for women in the postpartum is 2.5-5mg. This is usually increased to 10-20mg.
Possible Side Effects: Weight gain, sedation, low blood pressure, elevated prolactin, a restless feeling (akathisia), increase in blood lipids, hormonal changes, constipation, dry mouth.
Use in Pregnancy: Category B3
B3 indicates medication which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human foetus having been observed. Studies in animals have shown evidence of an increased occurrence of foetal damage, the significance of which is uncertain in humans.
Use in Lactation: Category L2
Drug which has been studied in a limited number of breast feeding women without an increase in adverse effects in the infant. And/or, the evidence of a demonstrated risk which is likely to follow use of this medication in a breast feeding woman is remote.